Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

May 6, 2024

John Celebi, the President and Chief Executive Officer of Sensei Biotherapeutics, emphasizes the need to develop better patient selection strategies and next-generation therapeutics for cancer patients. Through their Tumor Microenvironment-Activated Biologics platform (TMAb), Sensei develops conditionally...


May 6, 2024

John Celebi, the President and Chief Executive Officer of Sensei Biotherapeutics, emphasizes the need to develop better patient selection strategies and next-generation therapeutics for cancer patients. Through their Tumor Microenvironment-Activated Biologics platform (TMAb), Sensei develops conditionally...


Jan 17, 2024

Dr. Steve Marcus, CEO of Cantex Pharmaceuticals,  emphasizes the importance of the RAGE receptor in diseases like cancer and inflammation.  Their lead compound, azeliragon, blocks the activation of the RAGE receptor and shows effectiveness in inhibiting cancer metastasis and enhancing the impact of radiation. Clinical...


Jan 17, 2024

Dr. Steve Marcus, CEO of Cantex Pharmaceuticals,  emphasizes the importance of the RAGE receptor in diseases like cancer and inflammation.  Their lead compound, azeliragon, blocks the activation of the RAGE receptor and shows effectiveness in inhibiting cancer metastasis and enhancing the impact of radiation. Clinical...


Dec 14, 2023

Dr. Ruben Mesa, Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, discusses advancements in the treatment of myelofibrosis, chronic leukemia, a blood cancer characterized by scarring in the bone marrow.  Current therapies include stem cell transplants and ruxolitinib, a drug that helps...